You are now reading:
Asia AI-Augmented Insights | December 2025

Tel:
• 6532 7988
Complaint Management
• Hotline: 1800 22 22 228
• Calling from overseas: +65 6222 2228

Tel:
• 6532 7988
Complaint Management
• Hotline: 1800 22 22 228
• Calling from overseas: +65 6222 2228

Tel:
• 6532 7988
Complaint Management
• Hotline: 1800 22 22 228
• Calling from overseas: +65 6222 2228

Tel:
• 6532 7988
Complaint Management
• Hotline: 1800 22 22 228
• Calling from overseas: +65 6222 2228
you are in UOB Asset Management


You are now reading:
Asia AI-Augmented Insights | December 2025
Asian equity markets (MSCI Asia ex Japan Index, SGD terms) gained 2.0 percent in December, recouping much of November’s losses and ending 2025 near record highs. Gains were driven mainly by South Korea, Taiwan, China and ASEAN. There was a brief period of volatility as the Hong Kong markets dipped on renewed concerns about China’s economy, but this was offset by a surge in AI-related tech stocks.
South Korea’s market outperformed as SK Hynix surged nearly 23 percent and Samsung Electronics gained 19 percent, fuelled by a rebound in AI chip demand and improving sentiment.
Taiwan equities mirrored Korea’s trajectory, with strong momentum among leading chipmakers on sustained AI related semiconductor demand.
Hong Kong’s market slipped as pharmaceutical and biotech names declined sharply alongside several large cap banks.
Mainland China equities posted modest gains despite fresh signs of stalling economic growth. Investment decelerated sharply, money supply contracted, and retail sales growth cooled. Industrial output grew 4.8 percent, below forecasts and October’s pace. While a statistical correction and the end of a white goods incentive scheme may have skewed some prints, economists cautioned that industrial sectors could face more pressure next year from rising trade barriers.
Inflation trends were mixed. The Consumer Price Index (CPI) rose to a 21 month high, core inflation steadied, while the Producer Price Index (PPI) deteriorated. New home prices fell again.
On the positive end, exports rebounded after October’s surprise dip and imports rose, delivering a year to date trade surplus above US$ 1 trillion. December’s official and private manufacturing Purchasing Managers’ Indexes (PMIs) expanded for the first time in months, defying expectations of further contraction.
In contrast, ASEAN markets proved more resilient. Indonesia’s benchmark reached record highs, while Singapore, Malaysia, and the Philippines also posted advances, with the latter breaking a six-month losing streak.
Malaysia surprised with strong gains on robust economic indicators signalling continued growth, while Singapore’s Straits Times Index (STI) also registered notable gains to end near record highs.
India’s NSE Nifty 50 (Nifty) and S&P BSE Sensex (Sensex) fell amid continued foreign investor outflows and a record low rupee, dampening risk appetite.
China left its 1 year and 5 year Loan Prime Rates unchanged as expected, while the US delayed new tariffs on chip exports to China for another 18 months.
November exports from Singapore, South Korea, Taiwan, and India beat forecasts despite US tariff headwinds. However, PMI data for the month showed further manufacturing contraction in South Korea, Taiwan, and China, slower growth in India, and expansion across ASEAN.
Indonesia and the US prepared to sign a full trade agreement in late January 2026.
Thailand dissolved parliament, triggering elections by end January 2026. Meanwhile, its border tensions with Cambodia eased after a ceasefire.
United Asia Fund
| 1M | 1Y | 3Y | |
| United Asia Fund | 3.87% | 17.66% | 12.12% |
| Benchmark | 2.00% | 24.68% | 14.59% |
Source: Morningstar. Performance as of 31 December 2025, SGD basis, with dividends and distributions reinvested, if any. Fund refers to United Asia Fund – A SGD Acc. Benchmark: April 1992 – December 2011: MSCI AC FE ex-Japan; January 2012 to present: MSCI AC Asia ex-Japan. Performance figures for 1 month till 1 year show the per cent change, while performance figures above 1 year show the average annual compounded returns.

Source: Morningstar. Portfolio rebalancing as of 31 December 2025. Benchmark allocation as of 31 December 2025
Click here for more details on the Fund above.
United Greater China Fund
| 1M | 1Y | 3Y | |
| United Greater China Fund | 2.20% | 29.16% | 14.02% |
| Benchmark | 0.77% | 26.73% | 16.10% |
Source: Morningstar. Performance as of 31 December 2025, SGD basis, with dividends and distributions reinvested, if any. Fund refers to United Greater China Fund – A SGD Acc. Benchmark: MSCI Golden Dragon Index. Performance figures for 1 month till 1 year show the per cent change, while performance figures above 1 year show the average annual compounded returns.

Source: Morningstar. Portfolio rebalancing as of 31 December 2025. Benchmark allocation as of 31 December 2025. Note: Differences in country allocation between the Fund and Benchmark may arise from differing country classification methodologies which define Hong Kong-listed Chinese companies differently
Click here for more details on the Fund above.
United ASEAN Fund
| 1M | 1Y | 3Y | |
| United ASEAN Fund | 2.59% | 7.91% | 7.11% |
| Benchmark | 1.25% | 9.92% | 7.96% |
Source: Morningstar. Performance as of 31 December 2025, SGD basis, with dividends and distributions reinvested, if any. Fund refers to United ASEAN Fund – A SGD Acc. Benchmark: Jun 86 - Jan 93: 100% DBS 50; Feb 93 - Aug 98: 50% DBS 50, 50% KLEMAS; Sep 98 - May 00: 100% DBS 50; June 00 - May 06: 50% STI Index, 50% KLEMAS; June 06 - June 13: 50% STI Index, 50% KLCI; Jul 13 - present: MSCI ASEAN. Performance figures for 1 month till 1 year show the per cent change, while performance figures above 1 year show the average annual compounded returns.

Source: Morningstar. Portfolio rebalancing as of 31 December 2025. Benchmark allocation as of 31 December 2025
Click here for more details on the Fund above.
MSCI Data are exclusive property of MSCI. MSCI Data are provided “as is”, MSCI bears no liability for or in connection with MSCI Data. MSCI full disclaimer here.
All information in this publication is based upon certain assumptions and analysis of information available as at the date of the publication and reflects prevailing conditions and UOB Asset Management Ltd (“UOBAM”)'s views as of such date, all of which are subject to change at any time without notice. Although care has been taken to ensure the accuracy of information contained in this publication, UOBAM makes no representation or warranty of any kind, express, implied or statutory, and shall not be responsible or liable for the accuracy or completeness of the information.
Potential investors should read the prospectus of the fund(s) (the “Fund(s)”) which is available and may be obtained from UOBAM or any of its appointed distributors, before deciding whether to subscribe for or purchase units in the Fund(s). Returns on the units are not guaranteed. The value of the units and the income from them, if any, may fall as well as rise, and is likely to have high volatility due to the investment policies and/or portfolio management techniques employed by the Fund(s). Please note that the graphs, charts, formulae or other devices set out or referred to in this document cannot, in and of itself, be used to determine and will not assist any person in deciding which investment product to buy or sell, or when to buy or sell an investment product. An investment in the Fund(s) is subject to investment risks and foreign exchange risks, including the possible loss of the principal amount invested. Investors should consider carefully the risks of investing in the Fund(s) and may wish to seek advice from a financial adviser before making a commitment to invest in the Fund(s). Should you choose not to seek advice from a financial adviser, you should consider carefully whether the Fund(s) is suitable for you. Investors should note that the past performance of any investment product, manager, company, entity or UOBAM mentioned in this publication, and any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets is not necessarily indicative of the future or likely performance of any investment product, manager, company, entity or UOBAM or the economy, stock market, bond market or economic trends of the markets. Nothing in this publication shall constitute a continuing representation or give rise to any implication that there has not been or that there will not be any change affecting the Funds. All subscription for the units in the Fund(s) must be made on the application forms accompanying the prospectus of that fund.
The above information is strictly for general information only and is not an offer, solicitation advice or recommendation to buy or sell any investment product or invest in any company. This publication should not be construed as accounting, legal, regulatory, tax, financial or other advice. Investments in unit trusts are not obligations of, deposits in, or guaranteed or insured by United Overseas Bank Limited, UOBAM, or any of their subsidiary, associate or affiliate or their distributors. The Fund(s) may use or invest in financial derivative instruments, and you should be aware of the risks associated with investments in financial derivative instruments which are described in the Fund(s)' prospectus.
Please visit the following for more details on the funds, important notes and the respective funds' disclaimers.
United Asia Fund: https://www.uobam.com.sg/our-funds/highlights/united-asia-fund/index.page
United Greater China Fund: https://www.uobam.com.sg/our-funds/highlights/united-greater-china-fund/index.page
United ASEAN Fund: https://www.uobam.com.sg/our-funds/funds-details.page?mstarid=F0HKG062HL
This advertisement has not been reviewed by the Monetary Authority of Singapore.
UOB Asset Management Ltd Co. Reg. No. 198600120Z

02 Apr 2026 •

23 Dec 2025 •

26 Sep 2025 •